Medplus Health Services Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.4 pts more than Nifty Microcap 250 and 1.8 pts more than its Retailing peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Medplus Health Services Limited has submitted its financial results for the period ending March 31, 2025 to the NSE. This is a routine regulatory filing under the listing obligations, covering the company's audited results for the full financial year FY25 (or Q4 FY25). The headline alone does not disclose the actual revenue, profit, margin, or auditor commentary figures. Investors would need to refer to the detailed financial statements and auditor's report attached to this filing to assess performance trends, growth, and any qualifications.
This is a standard compliance filing and not an event-driven announcement, so it is unlikely to move the stock on its own. The market reaction will depend on the actual numbers, margins, and any forward guidance contained in the detailed results.